Side effects of lecanemab are manageable, study finds
Drug to slow Alzheimer’s well tolerated outside of clinical trial setting (Links to an external site)
Category: News
Uncertainty around NIH funding leaves Alzheimer’s studies in limbo (Links to an external site)
New blood test diagnoses Alzheimer’s disease and measures how far it’s progressed (Links to an external site)
The new test could also help confirm whether Alzheimer’s or another condition is causing a person’s symptoms.
Predicting cognitive decline in Alzheimer’s (Links to an external site)
New tests of blood and spinal fluid can show how far Alzheimer’s has progressed and how fast a patient’s memory will decline.
Researchers find a hint at how to delay Alzheimer’s symptoms. Now they have to prove it (Links to an external site)
Small study hints anti-amyloid therapy may keep Alzheimer’s symptoms at bay in certain patients (Links to an external site)
For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from the brains of people destined to develop Alzheimer’s dementia can delay the disease.
Anti-amyloid drug shows signs of preventing Alzheimer’s dementia (Links to an external site)
Clinical trial of people destined to develop early-onset Alzheimer’s disease shows eliminating amyloid from brain may prevent symptoms, supports need for confirmatory studies
Scientists Announce Possible Breakthrough in Delaying Alzheimer’s (Links to an external site)
Research announced today is the first of its kind to suggest that anti-amyloid drugs can delay or even stop the progression of symptoms in people with early-onset Alzheimer’s.
His genes forecast Alzheimer’s. His brain had other plans. (Links to an external site)
Patient defies genetic fate to avoid Alzheimer’s (Links to an external site)
Study offers clues to treatment, prevention